首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
SOSTANZE FURILICHE PER USO TOPICO
摘要
申请公布号
ITMI20011019(A1)
申请公布日期
2002.11.18
申请号
IT2001MI01019
申请日期
2001.05.17
申请人
GHISALBERTI CARLO
发明人
GHISALBERTI CARLO
分类号
A61K8/49;A61P17/00;A61P17/04;A61P17/06;A61P17/08;A61P17/16;A61Q19/00;A61Q19/08
主分类号
A61K8/49
代理机构
代理人
主权项
地址
您可能感兴趣的专利
ORGANIC LIGHT EMITTING DISPLAY DEVICE HAVING IMPROVED LIGHT EMITTING EFFICIENCY
OLED PACKAGE STRUCTURE AND PACKAGE METHOD THEREOF
Dopant-Free Polymeric Hole-Transporting Materials for Perovskite Solar Cell
ORGANIC TRANSISTOR, COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL FOR NON-LIGHT-EMITTING ORGANIC SEMICONDUCTOR DEVICE, MATERIAL FOR ORGANIC TRANSISTOR, COATING SOLUTION FOR NON-LIGHT-EMITTING ORGANIC SEMICONDUCTOR DEVICE, AND ORGANIC SEMICONDUCTOR FILM FOR NON-LIGHT-EMITTING ORGANIC SEMICONDUCTOR DEVICE
Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Heterocyclic Compound
METHOD OF MANUFACTURING LIGHT-EMITTING DISPLAY DEVICE AND LIGHT-EMITTING DISPLAY DEVICE MANUFACTURED USING THE METHOD
Display Module Manufacturing Method and Display Module
SACRIFICIAL SHORTING STRAPS FOR SUPERCONDUCTING QUBITS
SEMICONDUCTOR PACKAGE ASSEMBLY WITH THERMAL RECYCLING FUNCTION
THERMOELECTRIC MATERIAL, AND THERMOELECTRIC MODULE AND THERMOELECTRIC APPARATUS COMPRISING THE SAME
SEMICONDUCTOR LIGHT EMITTING DEVICE
TRENCH PROCESS AND STRUCTURE FOR BACKSIDE CONTACT SOLAR CELLS WITH POLYSILICON DOPED REGIONS
DNA vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the H5 haemagglutinin of an influenza virus and use of the DNA vaccine
Steroid compounds as RORyt modulators and uses thereof
Ruthenium (II) complexes, preparation and uses thereof
Process to prepare aluminoxanes by reaction of alkylaluminum with allylic alcohols
Process for preparing of bortezomib
Compositions and methods for modulating TLR4
Treprostinil derivative compounds and methods of using same
Substituted biphenyl amides as P2X<sub>3 </sub>and P2X<sub>2/3 </sub>antagonists
